Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

Presentation JIM 2019

LAA Occlusion In the Prevention of Stroke: Efficacy, Safety and Cost Benefit Is the Data Convincing?

Presenter: Maurice Buchbinder

February 14, 2019

Presentation The Structural Heart Disease Summit 2018

Beyond Iatrogenic Stroke: PFO Closure for Migraine and More

Presenter: John D. Carroll, Brij Maini, Robert J. Sommer

June 23, 2018

Presentation LAA 2017

PFO Case Reviews: To Close or Not to Close

Presenter: David E. Thaler

July 22, 2017

Presentation LAA 2017

Patient Selection and Outcomes of PFO Closure in Idiopathic Stroke: Lessons From RESPECT and Worldwide Registries

Presenter: David E. Thaler

July 22, 2017

Presentation LAA 2017

LAA Closure: Shared Decision Making Criteria and Documentation

Presenter: Megan Coylewright

July 21, 2017

Presentation LAA 2017

Left Atrial Appendage Occlusion as Adjunctive Therapy

Presenter: Amar Krishnaswamy

July 21, 2017

Presentation LAA 2017

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Presenter: Vivek Y. Reddy

July 21, 2017

Presentation LAA 2017

Risk Scores and Biomarkers for Stroke and Bleeding: Applications and Recommendations

Presenter: Megan Coylewright

July 21, 2017

Presentation EuroPCR 2016

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

Presenter: Jens Erik Nielsen-Kudsk

May 20, 2016

Presentation Scripps 2016

LAA Closure for Prevention of AF Stroke: Clinical Trial Data

Presenter: Brian Whisenant

February 04, 2016

Presentation Scripps 2016

LAA Closure for Stroke Prevention: Novel and Next Generation Devices

Presenter: Brian K. Whisenant

February 03, 2016

Presentation

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Presenter: Vivek Y. Reddy

December 13, 2015

Presentation

LAA Occlusion for Stroke Prevention in A-Fib

Presenter: Apostolos Tzikas

January 29, 2015

Presentation

PREVAIL: Prospective Randomized Evaluation of the Watchman LAA Closure Device in Patients with A-fib vs Long-term Warfarin Therapy

Presenter: David R. Holmes Jr.

June 30, 2014

Presentation

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Presenter: S.R. Gangireddy

September 26, 2012

Advertisement

LAA Occlusion In the Prevention of Stroke: Efficacy, Safety and Cost Benefit Is the Data Convincing?

Beyond Iatrogenic Stroke: PFO Closure for Migraine and More

PFO Case Reviews: To Close or Not to Close

Patient Selection and Outcomes of PFO Closure in Idiopathic Stroke: Lessons From RESPECT and Worldwide Registries

LAA Closure: Shared Decision Making Criteria and Documentation

Left Atrial Appendage Occlusion as Adjunctive Therapy

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Risk Scores and Biomarkers for Stroke and Bleeding: Applications and Recommendations

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

LAA Closure for Prevention of AF Stroke: Clinical Trial Data

LAA Closure for Stroke Prevention: Novel and Next Generation Devices

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

LAA Occlusion for Stroke Prevention in A-Fib

PREVAIL: Prospective Randomized Evaluation of the Watchman LAA Closure Device in Patients with A-fib vs Long-term Warfarin Therapy

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content